Jagsonpal Pharmaceuticals Q3 Results

  • BSE: 507789
  • NSE: JAGSNPHARM
  • ISIN: INE048B01027
  • Sector: Major Drugs
BSE
675.635.40 (5.53%)
Volume43.72 K
Updated: Mon 25 Nov, 2024 | 15:41:47
NSE
67133.30 (5.22%)
Volume3.97 L
Updated: Mon 25 Nov, 2024 | 15:42:00
Today: 643.30
686.80
52-Wk: 270.05
654.95

Q3 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Jagsonpal Pharmaceuticals Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 23Sep 23QoQ CompDec 22YoY Comp
    Total Revenue 47.2357.83-%60.14-%
    Selling/ General/ Admin Expenses Total 11.6411.70-%14.19-%
    Depreciation/ Amortization 0.410.45-%0.33-%
    Other Operating Expenses Total 9.8012.67-%10.49-%
    Total Operating Expense 44.2549.92-%51.84-%
    Operating Income 2.987.91-%8.30-%
    Net Income Before Taxes 5.289.96-%9.87-%
    Net Income 3.967.47-%7.78-%
    Diluted Normalized EPS 1.472.84-%2.97-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts